D W Siemann, R T Mulcahy. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » AnimalsAntineoplastic Combined Chemotherapy ProtocolsCarmustine/administration & dosageCell Survival/drug effectsDrug SynergismHeterocyclic Compounds/administration & dosageHeterocyclic Compounds/toxicityHydroxamic AcidsHypoxiaLomustine/administration & dosageMisonidazole/administration & dosageMisonidazole/toxicityNeoplasms, Experimental/drug therapyNitroimidazoles/administration & dosageNitroimidazoles/toxicityRadiation-Sensitizing Agents/administration & dosageRadiation-Sensitizing Agents/toxicity
Substances: See more » Heterocyclic CompoundsHydroxamic AcidsNitroimidazolesRadiation-Sensitizing Agentsacetohydroxamic acidLomustineMisonidazoleCarmustine
Year: 1986 PMID: 3940521 DOI: 10.1016/0006-2952(86)90567-8
Source DB: PubMed Journal: Biochem Pharmacol ISSN: 0006-2952 Impact factor: 5.858